ARTICLE | Company News
Pelago Bioscience, AstraZeneca deal
January 4, 2016 8:00 AM UTC
Pelago and AstraZeneca partnered to develop assay formats and applications of the Cellular Thermal Shift Assay (CETSA) across the range of AZ’s therapeutic areas. Under the two-year, non-exclusive dea...